Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCZ1F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,499
Award facts
- Contract value 100% obligated
- $27,499.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at approximately $27.5K, was awarded on January 12, 2026, to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., for the supply of Wegovy 2.4 mg/0.75 ml pens. The Defense Logistics Agency (DLA) issued this non-set-aside, competitively awarded contract with firm fixed pricing, with performance scheduled for completion by January 13, 2026, at the contractor's Conshohocken, Pennsylvania facility. This delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle extending through December 2026 that authorizes the supply of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical needs, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The parent organization, Cencora, Inc., holds the primary $1 billion IDC with DLA Troop Support Medical through December 2031, underscoring the company's significant role in supplying essential pharmaceuticals and medical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FCZ1F?
SPE2DR26FCZ1F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FCZ1F worth?
The government has obligated $27,499 on SPE2DR26FCZ1F.
Is contract SPE2DR26FCZ1F an order under another contract?
Yes. SPE2DR26FCZ1F is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCZ1F competed?
The extent of competition for SPE2DR26FCZ1F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award